Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$521M |
| 2 |
Nike
NKE
|
+$509M |
| 3 |
Micron Technology
MU
|
+$439M |
| 4 |
Super Micro Computer
SMCI
|
+$435M |
| 5 |
Broadcom
AVGO
|
+$329M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$5.31B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.89B |
| 3 |
Amazon
AMZN
|
+$1.48B |
| 4 |
Microsoft
MSFT
|
+$1.07B |
| 5 |
iShares Russell 2000 ETF
IWM
|
+$904M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 93% |
| 2 | Technology | 2.38% |
| 3 | Consumer Discretionary | 1.03% |
| 4 | Financials | 0.75% |
| 5 | Healthcare | 0.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
10351
PUT
Frontier Group Holdings
ULCC
$1.36B
| $193K | ﹤0.01% |
+39,200
| New | +$235K |
|
10352
Capricor Therapeutics
CAPR
$563M
| $193K | ﹤0.01% |
40,497
-275,763
| -87% | -$1.54M |
|
10353
CALL
Amylyx Pharmaceuticals
AMLX
$3.97B
| $193K | ﹤0.01% |
101,600
-648,000
| -86% | -$1.26M |
|
10354
AudioCodes
AUDC
$242M
| $193K | ﹤0.01% |
18,579
+4,941
| +36% | +$52.3K |
|
10355
PUT
Inhibrx
INBX
$1.79B
| $193K | ﹤0.01% |
+13,600
| New | +$212K |
|
10356
PUT
El Pollo Loco
LOCO
$469M
| $192K | ﹤0.01% |
+17,000
| New | +$169K |
|
|
VIGL
10357
DELISTED
Vigil Neuroscience
VIGL
| $192K | ﹤0.01% |
+48,051
| New | +$164K |
|
10358
China Automotive Systems
CAAS
$150M
| $192K | ﹤0.01% |
54,140
-161
| -0.3% | -$592 |
|
|
GOOD
10359
Gladstone Commercial Corp
GOOD
$631M
| $192K | ﹤0.01% |
+13,455
| New | +$187K |
|
10360
Intellicheck
IDN
$56.9M
| $192K | ﹤0.01% |
56,122
-29,269
| -34% | -$95.6K |
|
10361
CPI Aerostructures
CVU
$71.8M
| $192K | ﹤0.01% |
+77,690
| New | +$194K |
|
10362
Lexicon Pharmaceuticals
LXRX
$1.02B
| $192K | ﹤0.01% |
114,126
+103,283
| +953% | +$185K |
|
10363
OneSpan
OSPN
$610M
| $192K | ﹤0.01% |
14,954
-44,429
| -75% | -$534K |
|
|
SKE
10364
PUT
Skeena Resources
SKE
$4.14B
| $192K | ﹤0.01% |
35,700
-100
| -0.3% | -$471 |
|
10365
CALL
Real REMAX Group Inc. Common Stock
REAX
$490M
| $192K | ﹤0.01% |
4,720
+2,140
| +83% | +$89.9K |
|
10366
Amprius Technologies
AMPX
$1.45B
| $191K | ﹤0.01% |
+150,648
| New | +$246K |
|
10367
CALL
Arcos Dorados Holdings
ARCO
$1.68B
| $191K | ﹤0.01% |
21,200
-35,200
| -62% | -$362K |
|
10368
PUT
Arbutus Biopharma
ABUS
$1.01B
| $191K | ﹤0.01% |
61,700
+44,700
| +263% | +$134K |
|
10369
5E Advanced Materials
FEAM
$67.3M
| $191K | ﹤0.01% |
6,846
+4,747
| +226% | +$149K |
|
10370
Broadwind
BWEN
$102M
| $190K | ﹤0.01% |
+58,053
| New | +$173K |
|
10371
Good Times Restaurants
GTIM
$15.8M
| $190K | ﹤0.01% |
75,248
+6,959
| +10% | +$18.1K |
|
10372
PUT
Bally's
BALY
$476M
| $190K | ﹤0.01% |
15,900
-165,300
| -91% | -$2.11M |
|
10373
PUT
NCR Voyix
VYX
$1.22B
| $190K | ﹤0.01% |
15,400
-12,400
| -45% | -$156K |
|
|
PRST
10374
DELISTED
Presto Technologies, Inc. Common Stock
PRST
| $190K | ﹤0.01% |
2,715,573
+85,966
| +3% | +$12.5K |
|
10375
CALL
GH Research
GHRS
$1.93B
| $190K | ﹤0.01% |
+16,300
| New | +$196K |
|
Similar funds
Jeff Yass's Q2 2024 Portfolio in Review
As of Q2 2024, Jeff Yass held 13,638 positions worth $537B, down 6.7% from $576B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Jeff Yass's Q2 2024 filing shows 1,591 new, 4,593 increased, 5,607 reduced and 1,726 closed positions. Its largest new stake was NextEra Energy 7.299% Corporate Units: 2,575,000 shares worth $127M. The largest sale was NVIDIA, an estimated $5.31B.
By sector, the portfolio is most concentrated in Miscellaneous at 93% of assets, up from 93% a quarter earlier, followed by Technology and Consumer Discretionary.
- Jeff Yass's largest Q2 2024 buy was NextEra Energy 7.299% Corporate Units: 2,575,000 shares worth $127M.
- Jeff Yass added most to Vanguard FTSE Developed Markets ETF in Q2 2024, an estimated $521M increase.
- Jeff Yass's biggest Q2 2024 reduction was NVIDIA, cutting an estimated $5.31B.
- Jeff Yass fully exited iShares MSCI USA Quality Factor ETF in Q2 2024, selling an estimated $26.2M.
- Jeff Yass's ten largest holdings make up 26% of its $537B portfolio in Q2 2024.
- Jeff Yass opened 1,591 new positions and closed 1,726 in Q2 2024.
- Jeff Yass's portfolio value fell 6.7% quarter-over-quarter to $537B.
Based on Susquehanna International Group's 13F filing for Q2 2024, filed 15 Aug 2024.